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a  b  s  t  r  a  c  t
Background: COVID-19 is a new disease and the most common complication is pneumonia.
The  Radiological Society of North America (RSNA) proposed an expert consensus for imaging
classification for COVID-19 pneumonia.
Objective: To evaluate sensitivity, specificity, accuracy, and reproducibility of chest CT stan-
dards in the beginning of the Brazilian COVID-19 outbreak.
Methods: Cross-sectional study performed from March 1st to April 14th, 2020. Patients with
suspected COVID-19 pneumonia submitted to RT-PCR test and chest computed tomography
(CT) were included. Two thoracic radiologists blinded for RT-PCR and clinical and laboratory
results classified every patient scan according to the RSNA expert consensus. A third thoracic
radiologist also evaluated in case of discordance, and consensus was reached among the
three radiologists. A typical appearance was considered a positive chest CT for COVID-19
pneumonia. Sensitivity, specificity, positive and negative predictive values were calculated.
Cohen’s kappa coefficient was used to evaluate intra- and inter-rater agreements.
Results: A total of 159 patients were included (mean age 57.9 ± 18.0 years; 88 [55.3%] males):
86  (54.1%) COVID-19 and 73 (45.9%) non-COVID-19 patients. Eighty (50.3%) patients had a
positive CT for COVID-19 pneumonia. Sensitivity and specificity of typical appearance were
88.3%  (95%CI, 79.9–93.5) and 94.5% (95%CI, 86.7–97.8), respectively. Intra- and inter-rater
agreement were assessed (Cohen’s kappa = 0.924, P = 0.06; Cohen’s kappa=0.772, P = 0.05,
respectively).
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Conclusion: Chest CT categorical classification of COVID-19 findings is reproducible and
demonstrates high level of agreement with clinical and RT-PCR diagnosis of COVID-19. In
RT-PCR scarcity scenarios or in equivocal cases, it may be useful for attending physicians in
the  evaluation of suspected COVID-19 pneumonia patients attended at the emergency unit.
©  2020 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. This is












































oronavirus Disease 2019 (COVID-19) is a transmissible respi-
atory disease that rapidly spread around the globe. Since the
rst case reported in February 2020, Brazil has been severely
ffected by the epidemic and was the second most affected
ountry in the world, with over three million confirmed cases
nd more  than a 100,000 deaths by the first days of August.1,2
ince the early stage of COVID-19 outbreak in China, chest
omputed tomography (CT) has been used in the evaluation
f patients with suspected COVID-19 pneumonia in the emer-
ency setting, even though it has not been recommended for
outine screening or as an isolated diagnostic test.3,4
Although several radiological findings have been associ-
ted with COVID-19 pneumonia,5–9 their presence in other
iseases hamper CT’s reliability for this specific diagnosis.10
hest CT specificity has broadly ranged in different stud-
es, but the lack of standardized criteria impairs comparisons
etween them.11 Tomographic standards, such as the Radi-
logical Society of North America (RSNA) expert consensus,
ritish Society of Thoracic Imaging guidance for radiolog-
cal reporting and COVID-19 Reporting and Data System,
ave been proposed to overcome these limitations.12–16 These
roposed imaging classifications may help clinicians assess
he likelihood of COVID-19 pneumonia before molecular test
esults are available or in settings where the access to these
xams are limited.
So far, the majority of studies addressing the role of chest
T in the diagnosis of COVID-19 pneumonia evaluated its
erformance in Chinese or European populations.12,13,16 The
eproducibility of these findings may theoretically change
cross distinct regions of the globe due to potential differences
n the affected population or circulating viruses. In this study,
e aimed to evaluate sensitivity, specificity, accuracy, positive
nd negative predictive values and reproducibility of the RSNA
maging categories for COVID-19 pneumonia in patients eval-
ated at the emergency department of a referral center for
OVID-19 patients in the early period of COVID-19 pandemic
n Brazil.
aterials  and  methods
tudy  designhe institutional review board approved the study and
nformed consent was waived. This was a cross-sectional
tudy with patients presenting with fever or respiratory symp-
oms, from March 1st to April 14th, 2020, at a COVID-19licenses/by-nc-nd/4.0/).
dedicated area in the emergency unit of a private hospital.
All patients who collected a reverse transcriptase-polymerase
chain reaction (RT-PCR) for the diagnosis of COVID-19 were eli-
gible. The study included consecutive patients with suspected
pneumonia that underwent chest CT, at the discretion of the
attending physician. Chest CT was ordered according to the
institutional protocol taking into account pneumonia severity
criteria, laboratory tests and comorbidities. Exclusion criteria
were age <18 years, lack of data in medical records, and severe
respiratory motion artifacts on chest CT.
COVID-19 was confirmed with one positive RT-PCR result.
Patients with one negative RT-PCR result were considered
non-COVID-19 if clinical, laboratory, and radiological findings
indicated a low likelihood of COVID-19. Two consecutive (at
least 48 h apart) negative results were required for excluding
COVID-19 diagnosis in those judged to have a higher probabil-
ity of disease, according to the independent evaluation of two
infectious diseases specialists of institutional infection con-
trol team, as recommended by Infectious Diseases Society of
America Guidelines.17
Molecular  diagnosis
One oropharyngeal and two nasopharyngeal (from both nos-
trils) rayon swabs were collected. RNA extraction and real-time
RT-PCR were performed at an external laboratory (Grupo
Fleury), a reference private laboratory in Brazil, using primer
and probes according to the Charité protocol, as previously
described.18 Molecular tests for other respiratory pathogens
were performed per request of the attending physician, and
included either PCR for influenza A (H3N2 and H1N1),19
geneXpert® (Cepheid) for influenza A (H3N2 and H1N1) and
B, or FilmArray® PCR Multiplex (Biomérieux), including aden-
ovirus; coronavirus 229E, coronavírus HKU1, NL63 and OC43;
human metapneumovirus; influenza A (H3N2 and H1N1)
and B; parainfluenza 1,2, 3 e 4; and rhinovirus/enterovirus;
Syncytial Respiratory Virus; Bordetella pertussis; Chlamydophila
pneumoniae and Mycoplasma pneumoniae.
CT  image  acquisition
Imaging acquisitions were obtained with patients in the
supine position during end-inspiration without contrast
medium injection. Chest CT was performed on a 16-slice CT
(Siemens Emotion 16 Slice CT Scanner, Siemens Healthineers,
Forchheim, Germany) and 64-slice CT (Siemens Sensation
64 Slice CT Scanner, Siemens Healthineers, Forchheim, Ger-
many). The following technical parameters were used for both
CT scanners: tube voltage 130 kV; tube current modulation 100
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443 patients obtained RT-PCR for
SARS-CoV-2 after clinical evaluation
in a dedicated area for suspected
COVID-19 patients from March 1st to
April 14th 2020
Excluded:
Patients without chest CT (n = 280)
Excluded:
Respiratory motion artifact (n = 3)
Insufficient data (n = 1)

















Atypical chest CT (n = 17)Typical chest CT (n = 80) Indeterminate chest CT (n = 30)
159 patients were enrolled
163 patients: both RT-PCR and chest
CT
Fig. 1 – Fow diagram of study participants. Abbreviations: RT-PCR, Reverse Transcriptase Polymerase Chain Reaction;
SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; COVID-19, coronavirus disease 2019; CT, computed
tomography.
mAs; spiral pitch factor 1.4; collimation width 0.625. Recon-
structions were made with convolution kernel lung and soft
tissue at a slice thickness of 1.00 mm.  DICOM data were trans-
ferred onto a PACS workstation (Carestream Vue PACS version
12.1.6.1005, Carestream Health, NY, USA).
CT  image  analysis
All chest CT images were evaluated independently by two radi-
ologists with two and 10 years of thoracic imaging experience.
Both readers evaluated every patient scan twice with a 2-day
interval between readout sessions to assess intra and inter-
rater agreement. Discordant reports were evaluated by a third
thoracic radiologist with 12 years of experience and consen-
sus was reached among the three radiologists. All radiologists
were blinded for RT-PCR, clinical and laboratory results, and
previous imaging exams.
CT features were classified as "typical," "indeterminate,"
"atypical," and "negative" for COVID-19 pneumonia", accord-
ing to RSNA expert consensus.15 COVID-19 typical features
are peripheral, bilateral and multifocal rounded ground-glass
opacities (GGO) with or without consolidation or visible
intralobular lines (“crazy-paving”). Reversed halo sign and
other findings of organizing pneumonia can be seen later
in the disease. Indeterminate features may occur but are
nonspecific for COVID-19 pneumonia, such as diffuse, peri-
hilar, or unilateral GGO. All unusual or unreported findings
for COVID-19 were classified as atypical (e.g., centrilobular
nodules, tree-in-bud opacities, or lung cavitation). If no CT
suggestive findings of pneumonia were present, a negative
classification was assigned. A typical appearance was consid-
ered a positive chest CT for COVID-19.Statistical  analysis
Statistical analysis was performed using SPSS version 18.0
(2009, PASW Statistics for Windows. SPSS Inc. Chicago, IL,
USA). The association of CT findings and COVID-19 was
assessed by univariate analysis using 2 or Fisher’s exact test
for categorical and Student’s t or Wilcoxon Mann-Whitney
tests for continuous variables. Sensitivity, specificity, positive
and negative likelihood ratio of a positive CT for COVID-19
pneumonia were calculated. Intra- and inter-rater classi-
fication agreement beyond chance (appearance and each
specific CT findings) and internal consistency reliability were
evaluated with Cohen’s kappa and Cronbach’s alpha coeffi-
cients, respectively. Kappa coefficients of 0−0.20, 0.21−0.40,
0.41−0.60, 0.61−0.80, and 0.81–1.00 were considered to indi-
cate none to slight, fair, moderate, substantial, and almost
perfect agreement, respectively, and Cronbach’s alpha higher
than 0.70 reflects internal consistency.20,21 Positive predictive
value (PPV) and negative predictive value (NPV) of the classi-
fication according to distinct COVID-19 prevalence were also
estimated. A p < 0.05 was considered statistically significant.
Results
Patient  population  and  clinical  data
A total of 1176 patients underwent clinical evaluation for res-
piratory symptoms. In 443 (37.6%) RT-PCR for SARS-CoV-2 was
collected. Of these, a chest CT with suspected pneumonia was
reported for 163, four (2.4%) were excluded, and 159 (mean age,
57.9 ± 18.0 years; 88 [55.3%] males) were included in the study:
86 (54.1%) COVID-19 and 73 (45.9%) non-COVID-19 patients
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Fig. 1). Out of 36 (22.6%) patients admitted to the intensive
are unit during hospitalization, 24 (66.7%) were COVID-19 and
2 were (33.3%) non-COVID-19 patients.
Baseline, clinical and laboratory characteristics of patients
ere generally similar between COVID-19 and non-COVID-19
roups (Table 1). Age and sex were not significantly differ-
nt between both groups. Anosmia was significantly more
requent in COVID-19 group. The non-COVID group had a
horter median duration of symptoms before attendance at
mergency. COVID-19 patients had significantly lower oxygen
aturation at emergency admission, lower leukocyte, lympho-
yte, and platelets counts.
The median time between collecting nasal and oropharyn-
eal swabs and performing chest CT was 3.6 h (IQR, 1.6–8.3),
nd the median time from onset of symptoms to undergoing
T was seven days (IQR, 3–9). Eighty (93.0%) COVID-19 patients
ad their diagnosis confirmed in the first RT-PCR for SARS-
oV-2, while in 6 (7.0%) the first test was negative but the
econd was positive.
hest  CT  standards  accuracy  for  COVID-19
hest CT features were classified as typical in 80 (50.3%)
atients, as indeterminate in 30 (18.9%), as atypical in 17
10.7%) and as negative for COVID-19 pneumonia in 32 (20.1%).
he sensitivity, specificity, accuracy, positive and negative
ikelihood ratio of typical appearance were 88.3% (95%CI 79.9-
3.5%), 94.5% (95%CI 86.7-97.8%), 91.1% (95%CI 85.7-94.6%),
6.1 (95%CI 9.8-26.4) and 0.12 (95%CI 0.10−0.14), respectively.
he PPV and NPV of typical appearance were 95.0% (95%CI,
8.0%-98.0%) and 87.3% (95%CI, 79.4% - 92.5%), respectively.
PV and NPV according to distinct expected prevalence of
OVID-19 among patients with respiratory symptoms are dis-
layed in Fig. 2.
Only four patients presented a typical appearance and
ere not confirmed as COVID-19 in two RT-PCR exams; an
lternative diagnosis could not established in two cases and
ere considered as possible COVID-19 pneumonia by the
ttending physicians. Of the remaining two patients, one
ad pulmonary thromboembolism with pulmonary infarction
iagnosed through magnetic resonance angiography per-
ormed three days after chest CT and the other patient had
acterial community-acquired pneumonia. The typical find-
ng in these latter two patients was peripheral and bilateral
ounded GGO with consolidation.
Commonly typical features reported in COVID-19 pneumo-
ia were multifocal, rounded and peripheral GGO displaying a
ensitivity of 95.3% (95%CI 88.5-98.7), 82.5% (95%CI 72.8-89.9)
nd 81.7% (95%CI 71.6-89.3), respectively (Table 2; Fig. 3). All
atients with atypical appearance (n = 17) on chest CT were
ot diagnosed with COVID-19 by RT-PCR. Of these, accord-
ng to their attendant physician, 13 had the final diagnosis
f bacterial pneumonia, one had decompensated heart fail-
re and three had no confirmed alternative diagnosis. The
ost common findings among these patients were centrilob-lar nodules (n = 15) and tree-in-bud opacities (n = 7) (Fig. 4).
mong patients with indeterminate appearance (n = 30), seven
ad a positive RT-PCR for SARS-CoV-2. In this group, common
ndings were very few and non-rounded GGO (n = 4), diffuse0;2 4(6):524–533 527
GGO (n = 2), and unilateral features (n = 1) (Fig. 5). One of them
also had radiological features of pulmonary fibrosis.
Other  respiratory  pathogens
A total of 33 (41.2%) patients with typical findings were tested
for influenza by molecular methods (three of them for all
other pathogens described in Methods; two were patients with
negative SARS-CoV-2 RT-PCR) and none had positive results.
Molecular tests for influenza were negative in other five (16.7%;
one also negative for other pathogens), three (17.6%) and five
(15.6%; one also negative for other pathogens) patients with
indeterminate, atypical, and negative CT findings, respec-
tively.
Chest  CT  standards  intra-  and  inter-rater  reliability
Intra-rater agreement in assigned classification was seen in
282 (88.7%) of 318 observations. Regarding intra-rater agree-
ment, Cohen’s kappa of observer one was 0.847 (P = .13), and
observer two was 0.924 (P = .06). Inter-rater agreement ranged
from 0.725 (P = .001) to 0.772 (P = .05) between two radiologists
(see Tables S1 and S2). The agreement coefficients of selected
typical findings are shown in Table S3.
Discussion
Although Brazil is currently the second most affected country
worldwide in number of cases and deaths,1 there is little data
regarding chest CT evaluation of COVID-19 pneumonia in the
country, as well as in South-american population. Evaluation
of a diagnostic method in distinct populations is of paramount
importance to ensure reproducibility of the method in differ-
ent epidemiological scenarios, including potentially distinct
baseline clinical characteristics and circulating viruses. Our
study demonstrated that typical appearance on chest CT had
high specificity for COVID-19 pneumonia in a Brazilian pop-
ulation. The likelihood of COVID-19 pneumonia diagnosis in
patients with a typical CT pattern was substantially higher
(PLR = 16.1) than in patients with non-typical findings. Two
other studies have assessed the accuracy of the RSNA criteria
in Brazilian patients.22,23 In the study of Santos et al. both sen-
sitivity (83%) and specificity (97%) were similar to our results.
Barbosa et al. evaluated oncologic patients and found lower
sensitivity (64.0%) and specificity (84.8%) rates in that specific
population. These results are comparable to those demon-
strated in a recent study evaluating Italian patients, in which
the authors used the same radiological criteria and found
that a typical pattern had an specificity of 91.6% for COVID-
19 pneumonia.24 Other Chinese and Italian studies performed
in the early COVID-19 pandemic showed much lower speci-
ficity rates (25.0% to 56.0%) for chest CT;6,25 However, those
studies have not addressed the chest CT criteria proposed by
RSNA, which may have affected their results owing to the lack
of standards in CT interpretation.6,25 Finally, a recent meta-
analysis found a pooled specificity of 37.0% for chest CT.26
However, as considered by the authors, there was significant
heterogeneity among the studies.26 We believe that it was




























Fig. 2 – Positive and negative predictive values of a positive chest computed tomography (CT) according to distinct
prevalences of COVID-19. A positive chest CT was defined as a typical appearance. Error bars indicate 95% confidence
intervals (CI).
Positive predictive values (%) and 95% CI according to each estimated prevalence (P): P 10% - 63.6 (40.8-81.9); P 20% - 80.0
(62.5-90.9); P 30% - 87.5 (74.0-94.8); P 40% - 91.8 (81.1-96.9); P 50% - 94.6 (86.0-98.2); P 60% - 96.5 (89.5-99.1); P 70% - 98.0
(92.2-99.6); P 80% - 98.2 (93.1-99.7); P 90% - 99.2 (95.0-99.9).
Negative predictive values (%) and 95% CI according to each estimated prevalence (P): P 10% - 98.5 (94.3-99.7); P 20% - 96.7
(91.4 - 98.9); P 30% - 94.6 (88.1-97.7); P 40% - 92.7 (85.2-96.8); P 50% - 89.3 (80.1-94.6); P 60% - 84.5 (73.5-91.6); P 70% - 77.6
(64.4-87.0); P 80% - 66.6 (50.9-79.5); P 90% - 46.8 (29.5-64.9).
Fig. 3 – Nonenhanced high-resolution chest CT of different patients with confirmed COVID-19 pneumonia and typical
findings. A, 74-year-old man  presented with 7-day history of fever and cough. Axial CT shows multifocal, peripheral and
rounded ground glass opacities (GGO). B, 47-year-old man  presented with 10-day history of moderate breathlessness and
fever. Axial CT shows reversed halo sign. C, 70-year-old woman presented with 9-day history of mild dyspnea and
COVID-19 exposure. Axial CT shows GGO with a perilobular pattern. D, 36-year-old man  presented with 5-day history of
fever, cough and myalgia. Axial CT shows bilateral areas of crazy-paving pattern.
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Fig. 4 – Nonenhanced high-resolution chest CT of different patients with atypical findings. A, 52-year-old man  presented
with 3-day history of fever, cough and adynamia. Axial chest CT shows centrilobular nodules, tree-in-bud opacities and
bronchial mucocele. The patient was diagnosed with pulmonary tuberculosis. B, 26-year-old woman presented with 10-day
history of cough, sputum, fever and dyspnea. Axial chest CT shows lobar consolidation. The patient was diagnosed with
bacterial acquired community pneumonia. C, 47-year-old woman presented with 30-day history of headache, adynamia,
cough and chest pain. Axial chest CT shows pulmonary cavitation with satellite centrilobular opacities. The patient was
diagnosed with central nervous system and pulmonary cryptococcosis. D, 55-year-old man  presented with 3-day history of
orthopnea, precordial pain and cough. Axial chest CT shows bilateral pleural effusion, interlobular septal thickening, and
centrilobular ground glass opacities. The patient was diagnosed with congestive heart failure due to myocardial infarction.
Fig. 5 – Nonenhanced high-resolution chest CT of different patients with indeterminate findings. A, 40-year-old man
presented with 5-day history of worsening of chronic cough, dyspnea and fever. Axial CT shows diffuse and bilateral
ground glass opacities. The patient was diagnosed with acquired immunodeficiency syndrome and Pneumocystis
pneumonia. B, 55-year-old man  presented with 3-day history of cough and mild breathlessness. Axial CT shows unilobar,
rounded and peribroncovascular ground glass opacity. COVID-19 pneumonia was confirmed.
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Table 1 – Baseline characteristics, presentation signs and symptoms and laboratory results.a
COVID-19 Diagnosis
Total patients
(n = 159), No. (%)
Yes
(n  = 86), No. (%)
No
(n  = 73), No. (%)
P-value
Demographic Information
Age, mean (SD), y 57.9 (18.0) 60.0 (15.2) 55.4 (20.6) .12
Male 88 (55.3) 53 (61.6) 35 (47.9) .10
Comorbidities 103 (64.8) 58 (67.4) 45 (61.6) .40
Cancer 11 (6.9) 6 (7) 5 (6.8) >.99
Hypertension 52 (32.7) 31 (36) 21 (28.8) .31
Coronary artery disease 8 (5) 3 (3.5) 5 (6.8) .57
Congestive heart failure 3 (1.9) 0 (0) 3 (4.1) .19
Diabetes 20 (12.6) 13 (15.1) 7 (9.6) .38
Hematologic disease 2 (1.3) 1 (1.2) 1 (1.4) >.99
Immunosuppression 8 (5) 3 (3.5) 5 (6.8) .57
Liver disease 2 (1.3) 2 (2.3) 0 (0) .54
Obesity (BMI ≥ 30) 97 (61.0) 56 (65.1) 41 (56.2) .64
Pulmonary disease 33 (20.8) 14 (16.3) 19 (26.0) .21
Smoker 7 (4.4) 2 (2.3) 5 (6.8) .33
Signs and symptoms
Anosmia 9 (5.7) 9  (10.5) 0 (0) .01
Chest pain 19  (11.9) 5 (5.8) 14  (19.2) .02
Cough 114 (71.7) 67 (77.9) 47 (64.4) .06
Diarrhea 1 (0.6) 1 (1.2) 0 (0) .57
Dyspnea 86 (54.1) 49 (57.0) 37 (50.7) .42
Fatigue 82 (51.6) 29 (57.0) 33 (45.2) .15
Headache 41 (25.8) 19 (22.1) 22 (30.1) .35
Myalgia 55 (34.6) 35 (40.7) 20 (27.4) .09
Rhinorrhea 36 (22.6) 18 (20.9) 18 (24.7) .74
Temperature ≥ 37.8 ◦C 35 (22.0) 23 (26.7) 12 (16.4) .14
Oxygen saturation ≤93% 31 (19.5) 23 (26.7) 8 (11.0) .006
Initial laboratory measures
Leukocytes, median (IQR), /mm3 6820 (4915−9540) 5930 (4460−7510) 9230 (6760−11480) .001
Lymphocyte, median (IQR), /mm3 1290 (880−1785) 1165 (850−1510) 1610 (970−2150) .005
Platelets, median (IQR), /mm3 188.000 (253.000−144.500) 166.000 (130.000−204.000) 218.000 (179.000−273.000) .001
C-reactive protein, median (IQR), mg/dL 3.75 (1.10−7.30) 4.00 (1.80−7.30) 3.50 (0.60−7.30) .22
Creatinine, mg/dL, median (IQR), mg/dL 0.90 (0.70−1.10) 0.90 (0.70−1.10) 0.90 (0.70−1.05) .86
d-dimer, median (IQR), ng/mL 512.0 (349.0−795.0) 512.0 (286.5−773.0) 479.0 (336.0−1256.0) .96
Abbreviations: COVID-19, coronavirus disease 2019; SD, standard deviation; BMI, body mass index; IQR, interquartile range.
Please note, subtitles rows do not have data.
lecteda Presentation symptoms, vital signs, and laboratory results were se
patients with COVID-19.
mostly caused by the fact that studies using non-standardized
criteria for interpretation were included in the analysis.
Only four patients with typical CT findings were not diag-
nosed with COVID-19 by RT-PCR. Although all had negative
RT-PCRs, this diagnosis could not be ruled out in at least
two of them, who  had no alternative diagnosis during hos-
pitalization (Fig. 6). Additionally, one patient had pulmonary
embolism, which is a possible complication described in
COVID-19 patients.27 Other studies also showed similar find-
ings related to some false negative RT-PCR results with typical
chest CT appearance.28–31
A previous study has assessed the RSNA classification
inter-rater reliability, with moderate to substantial agreement
results.32 Our study reinforces these findings, demonstrat-
ing an almost perfect intra-rater and substantial inter-rater
agreements. These are encouraging outcomes, suggesting that
the classification may be useful for clinicians to accurately
estimate their suspicion for COVID-19 pneumonia before RT-
PCR results become available and increase the confidence in to be included according to the relevance to the characterization of
imaging classification, especially in settings where molecular
tests are restricted or unavailable. Actually, in pandemic sce-
narios where the expected COVID-19 prevalence in patients
with respiratory symptoms is above 30%, the PPV of typical
CT appearance was higher than 80%. Moreover, it was higher
than 90% when the prevalence was above 40%, making imag-
ing classification a reliable tool to identify highly suspicious
cases of SARS-CoV-2 pneumonia.
Even though typical appearance sensitivity was near 90%,
it is not possible to rule out the diagnosis with a non-typical
appearance, particularly in the high prevalence scenario. Pre-
vious studies suggested a high sensitivity for CT; however, the
lack of clear definitions for positive CT findings impairs the
generalizability of those findings.25,26,33 On the other hand,
it is important to highlight that the diagnosis of COVID-19
pneumonia was correctly excluded in all patients classified
as atypical, suggesting that this classification may be useful
to discourage the diagnosis of COVID-19 pneumonia. Seven
of 86 (8.1%) COVID-19 patients presented an indeterminate
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Table 2 – Association between typical findings and COVID-19 pneumonia diagnosis.
COVID-19 Diagnosis
CT findings Patients (n = 159)
No. (%)
Yes  (n = 86)
No. (%)
































































































































Abbreviations: COVID-19, coronavirus disease 2019; CT, computed tomography; CI, confidence interval; GGO, ground-glass opacities.
a Considered as other findings of organizing pneumonia seen later in the disease.
Fig. 6 – Nonenhanced high-resolution chest CT of a 79-year-old man  presented with 7-day history of dyspnea, adynamia
and COVID-19 exposure (wife and job colleague diagnosed with SARS-CoV-2 pneumonia). A and B, axial, C, sagittal chest
CT shows a typical appearance, with bilateral and rounded ground-glass opacities with predominant peripheral
distribution. The diagnosis of COVID-19 pneumonia couldn’t be ruled out, even though with two negative RT-PCR. The













n a 6-month follow-up visit.
T classification. This means that the diagnosis of COVID-19
neumonia cannot be confirmed or ruled out in patients with
n indeterminate CT.
Among typical findings, the most frequent were multifo-
al and rounded GGO, crazy-paving, and perilobular pattern,
sually peripheral and bilateral. Interestingly, despite dis-
ordance among readers regarding some isolated typical
T signs, there was agreement in the final standard. It is
oteworthy that each radiological finding should not be con-
idered individually, considering that these features are not
niquely related to COVID-19 pneumonia. Even noninfec-
ious diseases may present findings that might overlap withCT features related to SARS-CoV-2 infection, such as pul-
monary edema, organizing pneumonia, drug-related toxicity,
pulmonary infarcts, and interstitial lung diseases.34–37 Fur-
thermore, coinfection with other viruses cannot be ruled
out using only chest CT. However, it is noteworthy that the
study was conducted in a period before the influenza sea-
son in our region and, in addition to our data on molecular
tests for influenza, it should be highlighted that, during the
study period, only one case of severe acute respiratory syn-
drome caused by influenza was reported to the Municipal
Health Secretary, in mid  March and from another institution
(https://opendatasus.saude.gov.br/dataset/bd-srag-2020).








532  b r a z j i n f e c t d 
Our study has limitations and must be interpreted accord-
ingly. First, there was not a previously defined criteria for
ordering RT-PCR and chest CT and, during the study period,
RT-PCR was mostly collected from patients showing signs of
moderate or severe disease. Therefore, COVID-19 patients pre-
senting with mild disease and pneumonia could have been
discharged with no further imaging and laboratory inves-
tigations. Second, it was a single-center experience with
thorax-experienced radiologists, and scans readings may be
less precise when evaluated by general radiologists. Third, our
findings are applicable to patients with acute moderate and
severe respiratory symptoms performing chest CT during a
COVID-19 epidemic period. Finally, alternative diagnoses for
non-COVID-19 patients were not fully evaluated in all patients.
However, as discussed above, two of the four patients with
ẗypicaläppearance and negative RT-PCR were considered as
non-laboratory confirmed COVID-19 by attendant physicians
before hospital discharge.
In conclusion, in patients with suspected COVID-19 pneu-
monia, chest CT categorical classification of COVID-19 findings
is reproducible and demonstrates high agreement with clin-
ical and RT-PCR diagnosis of COVID-19. Our study reinforces
the role of tomographic standards to improve accuracy of radi-
ological reports and to help physicians diagnosing COVID-19
pneumonia.
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